United States Medical Hemostatic Agents Market Report 2017

United States Medical Hemostatic Agents Market Report 2017

1 Medical Hemostatic Agents Overview

1.1 Product Overview and Scope of Medical Hemostatic Agents

1.2 Classification of Medical Hemostatic Agents by Product Category

1.2.1 United States Medical Hemostatic Agents Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Medical Hemostatic Agents Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Gelation Sponge

1.2.4 Oxidized Regenerated Cellulose Based Hemostats

1.2.5 Others

1.3 United States Medical Hemostatic Agents Market by Application/End Users

1.3.1 United States Medical Hemostatic Agents Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Surgical Centers

1.3.4 Clnics

1.3.5 Others

1.4 United States Medical Hemostatic Agents Market by Region

1.4.1 United States Medical Hemostatic Agents Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Medical Hemostatic Agents Status and Prospect (2012-2022)

1.4.3 Southwest Medical Hemostatic Agents Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Medical Hemostatic Agents Status and Prospect (2012-2022)

1.4.5 New England Medical Hemostatic Agents Status and Prospect (2012-2022)

1.4.6 The South Medical Hemostatic Agents Status and Prospect (2012-2022)

1.4.7 The Midwest Medical Hemostatic Agents Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Medical Hemostatic Agents (2012-2022)

1.5.1 United States Medical Hemostatic Agents Sales and Growth Rate (2012-2022)

1.5.2 United States Medical Hemostatic Agents Revenue and Growth Rate (2012-2022)

2 United States Medical Hemostatic Agents Market Competition by Players/Suppliers

2.1 United States Medical Hemostatic Agents Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Medical Hemostatic Agents Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Medical Hemostatic Agents Average Price by Players/Suppliers (2012-2017)

2.4 United States Medical Hemostatic Agents Market Competitive Situation and Trends

2.4.1 United States Medical Hemostatic Agents Market Concentration Rate

2.4.2 United States Medical Hemostatic Agents Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Medical Hemostatic Agents Manufacturing Base Distribution, Sales Area, Product Type

3 United States Medical Hemostatic Agents Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Medical Hemostatic Agents Sales and Market Share by Region (2012-2017)

3.2 United States Medical Hemostatic Agents Revenue and Market Share by Region (2012-2017)

3.3 United States Medical Hemostatic Agents Price by Region (2012-2017)

4 United States Medical Hemostatic Agents Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Medical Hemostatic Agents Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Medical Hemostatic Agents Revenue and Market Share by Type (2012-2017)

4.3 United States Medical Hemostatic Agents Price by Type (2012-2017)

4.4 United States Medical Hemostatic Agents Sales Growth Rate by Type (2012-2017)

5 United States Medical Hemostatic Agents Sales (Volume) by Application (2012-2017)

5.1 United States Medical Hemostatic Agents Sales and Market Share by Application (2012-2017)

5.2 United States Medical Hemostatic Agents Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Medical Hemostatic Agents Players/Suppliers Profiles and Sales Data

6.1 Ethicon

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Medical Hemostatic Agents Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Ethicon Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Pfizer

6.2.2 Medical Hemostatic Agents Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Pfizer Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Baxter International

6.3.2 Medical Hemostatic Agents Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Baxter International Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 C. R. Bard

6.4.2 Medical Hemostatic Agents Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 C. R. Bard Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 The Medicines Company

6.5.2 Medical Hemostatic Agents Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 The Medicines Company Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Anika Therapeutics

6.6.2 Medical Hemostatic Agents Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Anika Therapeutics Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Advanced Medical Solutions

6.7.2 Medical Hemostatic Agents Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Advanced Medical Solutions Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Integra LifeSciences

6.8.2 Medical Hemostatic Agents Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Integra LifeSciences Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 B Braun Melsungen

6.9.2 Medical Hemostatic Agents Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 B Braun Melsungen Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Gelita Medical

6.10.2 Medical Hemostatic Agents Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Gelita Medical Medical Hemostatic Agents Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Equimedical

6.12 Vascular Solutions

6.13 Marine Polymer Technologies

6.14 Z-Medica

6.15 CryoLife

6.16 BioCer Entwicklungs

6.17 Biom’Up SAS

7 Medical Hemostatic Agents Manufacturing Cost Analysis

7.1 Medical Hemostatic Agents Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Medical Hemostatic Agents

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Medical Hemostatic Agents Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Medical Hemostatic Agents Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Medical Hemostatic Agents Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Medical Hemostatic Agents Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Medical Hemostatic Agents Sales Volume Forecast by Type (2017-2022)

11.3 United States Medical Hemostatic Agents Sales Volume Forecast by Application (2017-2022)

11.4 United States Medical Hemostatic Agents Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Medical Hemostatic Agents

Figure United States Medical Hemostatic Agents Market Size (K Units) by Type (2012-2022)

Figure United States Medical Hemostatic Agents Sales Volume Market Share by Type (Product Category) in 2016

Figure Gelation Sponge Product Picture

Figure Oxidized Regenerated Cellulose Based Hemostats Product Picture

Figure Others Product Picture

Figure United States Medical Hemostatic Agents Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Medical Hemostatic Agents by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Surgical Centers Examples

Table Key Downstream Customer in Surgical Centers

Figure Clnics Examples

Table Key Downstream Customer in Clnics

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Medical Hemostatic Agents Market Size (Million USD) by Region (2012-2022)

Figure The West Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Medical Hemostatic Agents Sales (K Units) and Growth Rate (2012-2022)

Figure United States Medical Hemostatic Agents Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Medical Hemostatic Agents Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Medical Hemostatic Agents Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Medical Hemostatic Agents Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Medical Hemostatic Agents Sales Share by Players/Suppliers

Figure 2017 United States Medical Hemostatic Agents Sales Share by Players/Suppliers

Figure United States Medical Hemostatic Agents Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Medical Hemostatic Agents Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Medical Hemostatic Agents Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Medical Hemostatic Agents Revenue Share by Players/Suppliers

Figure 2017 United States Medical Hemostatic Agents Revenue Share by Players/Suppliers

Table United States Market Medical Hemostatic Agents Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Medical Hemostatic Agents Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Medical Hemostatic Agents Market Share of Top 3 Players/Suppliers

Figure United States Medical Hemostatic Agents Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Medical Hemostatic Agents Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Medical Hemostatic Agents Product Category

Table United States Medical Hemostatic Agents Sales (K Units) by Region (2012-2017)

Table United States Medical Hemostatic Agents Sales Share by Region (2012-2017)

Figure United States Medical Hemostatic Agents Sales Share by Region (2012-2017)

Figure United States Medical Hemostatic Agents Sales Market Share by Region in 2016

Table United States Medical Hemostatic Agents Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Medical Hemostatic Agents Revenue Share by Region (2012-2017)

Figure United States Medical Hemostatic Agents Revenue Market Share by Region (2012-2017)

Figure United States Medical Hemostatic Agents Revenue Market Share by Region in 2016

Table United States Medical Hemostatic Agents Price (USD/Unit) by Region (2012-2017)

Table United States Medical Hemostatic Agents Sales (K Units) by Type (2012-2017)

Table United States Medical Hemostatic Agents Sales Share by Type (2012-2017)

Figure United States Medical Hemostatic Agents Sales Share by Type (2012-2017)

Figure United States Medical Hemostatic Agents Sales Market Share by Type in 2016

Table United States Medical Hemostatic Agents Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Medical Hemostatic Agents Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Medical Hemostatic Agents by Type (2012-2017)

Figure Revenue Market Share of Medical Hemostatic Agents by Type in 2016

Table United States Medical Hemostatic Agents Price (USD/Unit) by Types (2012-2017)

Figure United States Medical Hemostatic Agents Sales Growth Rate by Type (2012-2017)

Table United States Medical Hemostatic Agents Sales (K Units) by Application (2012-2017)

Table United States Medical Hemostatic Agents Sales Market Share by Application (2012-2017)

Figure United States Medical Hemostatic Agents Sales Market Share by Application (2012-2017)

Figure United States Medical Hemostatic Agents Sales Market Share by Application in 2016

Table United States Medical Hemostatic Agents Sales Growth Rate by Application (2012-2017)

Figure United States Medical Hemostatic Agents Sales Growth Rate by Application (2012-2017)

Table Ethicon Basic Information List

Table Ethicon Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Ethicon Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Ethicon Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Ethicon Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Pfizer Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Pfizer Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Baxter International Basic Information List

Table Baxter International Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Baxter International Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Baxter International Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Baxter International Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table C. R. Bard Basic Information List

Table C. R. Bard Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure C. R. Bard Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure C. R. Bard Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure C. R. Bard Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table The Medicines Company Basic Information List

Table The Medicines Company Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure The Medicines Company Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure The Medicines Company Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure The Medicines Company Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Anika Therapeutics Basic Information List

Table Anika Therapeutics Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Anika Therapeutics Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Anika Therapeutics Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Anika Therapeutics Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Advanced Medical Solutions Basic Information List

Table Advanced Medical Solutions Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Advanced Medical Solutions Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Advanced Medical Solutions Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Advanced Medical Solutions Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Integra LifeSciences Basic Information List

Table Integra LifeSciences Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Integra LifeSciences Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Integra LifeSciences Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Integra LifeSciences Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table B Braun Melsungen Basic Information List

Table B Braun Melsungen Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure B Braun Melsungen Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure B Braun Melsungen Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure B Braun Melsungen Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Gelita Medical Basic Information List

Table Gelita Medical Medical Hemostatic Agents Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Gelita Medical Medical Hemostatic Agents Sales Growth Rate (2012-2017)

Figure Gelita Medical Medical Hemostatic Agents Sales Market Share in United States (2012-2017)

Figure Gelita Medical Medical Hemostatic Agents Revenue Market Share in United States (2012-2017)

Table Equimedical Basic Information List

Table Vascular Solutions Basic Information List

Table Marine Polymer Technologies Basic Information List

Table Z-Medica Basic Information List

Table CryoLife Basic Information List

Table BioCer Entwicklungs Basic Information List

Table Biom’Up SAS Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Medical Hemostatic Agents

Figure Manufacturing Process Analysis of Medical Hemostatic Agents

Figure Medical Hemostatic Agents Industrial Chain Analysis

Table Raw Materials Sources of Medical Hemostatic Agents Major Players/Suppliers in 2016

Table Major Buyers of Medical Hemostatic Agents

Table Distributors/Traders List

Figure United States Medical Hemostatic Agents Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Medical Hemostatic Agents Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Medical Hemostatic Agents Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Type in 2022

Table United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Application in 2022

Table United States Medical Hemostatic Agents Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Medical Hemostatic Agents Sales Volume Share Forecast by Region (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume Share Forecast by Region (2017-2022)

Figure United States Medical Hemostatic Agents Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources